Autoimmune polyendocrine syndrome type 2 in patient with severe allergic asthma treated with omalizumab

Anna RamsDepartment of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland

, MD,

Marek ŻółcińskiDepartment of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland

, MD, PhD,

Weronika ZastrzeżyńskaDepartment of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland

, MD,

Stanisław PolańskiDepartment of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland

, MSc,

Agnieszka SerafinDepartment of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland

, MSc,

Joanna WilańskaDepartment of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland

, MSc,

Jacek MusiałDepartment of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland

, MD, PhD &

Stanisława Bazan-SochaDepartment of Internal Medicine, Jagiellonian University Medical College, Krakow, PolandCorrespondence[email protected]

, MD, PhD show all

References

Albers FC, Müllerová H, Gunsoy NB, Shin JY, Nelsen LM, Bradford ES, et al. Biologic treatment eligibility for real-world patients with severe asthma: the IDEAL study. J Asthma 2017:1–9. doi:10.1080/02770903.2017.1322611.
PubMed Web of Science ®Google Scholar
Bornstein SR, Allolio B, ArltW, Barthel A, Don-Wauchope A, Hammer GD, et al. Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2016;101:364–389. doi:10.1210/jc.2015-1710. Epub 2016 Jan 13.
PubMed Web of Science ®Google Scholar
Kahaly GJ. Polyglandular autoimmune syndromes. Eur. J Endocrinol 2009;161:11–20. doi:10.1080/02770903.2017.1322611.
PubMed Web of Science ®Google Scholar
Fourati H, Bouzid D, Abida O, Kharrat N, Mnif F, Haddouk S, et al. Non-HLA autoimmunity genetic factors contributing to autoimmune Polyglandular Syndrome type II in Tunisian patients. Hum Immunol 2012;73:740–746. doi:10.1016/j.humimm.2012.04.013.
PubMed Web of Science ®Google Scholar
Togias A, Gill MA, Sorkness CA, Arbes SJ Jr, Calatroni A, Wildfire JJ, et al. Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations. J Allergy Clin Immunol 2015;136:1476–1485. doi:10.1016/j.jaci.2015.09.008.
PubMed Web of Science ®Google Scholar
Krysiak R, Boldys A, Okopien B. Autoimmune polyglandular syndrome type 2 induced by treatment with interferon alpha. Am J Med Sci 2011;341:504–507. doi:10.1097/MAJ.0b013e31820ff7af.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Autoimmune polyendocrine syndrome type 2 in patient with severe allergic asthma treated with omalizumab

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Autoimmune polyendocrine syndrome type 2 in patient with severe allergic asthma treated with omalizumab

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date